Aminoglycosides for specialist use (Formulary)

Use only in accordance with protocols or on advice of Microbiology, Infectious Diseases or appropriate Consultant Specialist.

MHRA advice: Aminoglycosides (gentamicin, amikacin, tobramycin, and neomycin): increased risk of deafness in patients with mitochondrial mutations (January 2021) (www.gov.uk).

AMIKACIN

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Injection 500mg/2mL (Protected antibiotic to be prescribed on the advice of an infection specialist only) 

NEOMYCIN

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Tablets 500mg unlicensed (Protected antibiotic to be prescribed on the advice of an infection specialist only)

TOBRAMYCIN

Important: Therapy notes

Important: Formulation and dosage details

Formulation:

Injection 40mg/mL, 80mg/2mL (Protected antibiotic to be prescribed on the advice of an infection specialist only) 

Important: Formulation and dosage details

Formulation:

Nebuliser solution 300mg/4mL (Protected antibiotic to be prescribed on the advice of an infection specialist only) 

Important: Formulation and dosage details

Formulation:

Dry powder for inhalation 28mg/capsule (Tobi® Podhaler) (Protected antibiotic to be prescribed on the advice of an infection specialist only) 

Editorial Information

Document Id: F270